For: | Leowattana W, Leowattana P, Leowattana T. Systemic treatment for metastatic colorectal cancer. World J Gastroenterol 2023; 29(10): 1569-1588 [PMID: 36970592 DOI: 10.3748/wjg.v29.i10.1569] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i10/1569.htm |
Number | Citing Articles |
1 |
Liuxu Yao, Wen Zhai, Zongming Jiang, Rui He, Weiying Xie, Yuhong Li, Yiyang Hu. The Inhibitory Effects of Propofol on Colorectal Cancer Progression through the
NF-κB/HIF-1α Signaling Pathway. Anti-Cancer Agents in Medicinal Chemistry 2024; 24(11): 878 doi: 10.2174/0118715206283884240326170501
|
2 |
Yilin Yu, Haixia Wu, Liang Hong, Jianjian Qiu, Shiji Wu, Lingdong Shao, Cheng Lin, Zhiping Wang, Junxin Wu. A large population-based and validated study on the follow-up management and supportive strategy of locally advanced rectal cancer patients. Supportive Care in Cancer 2024; 32(10) doi: 10.1007/s00520-024-08860-1
|
3 |
Xinying Zhou, Yu Zhao, Rongchuan Zhao, Shaheryar Shafi, Yue Yang, Guangxing Liu, Song-Bai Liu. Research progress of intestinal microbiota in targeted therapy and immunotherapy of colorectal cancer. Journal of Cancer Metastasis and Treatment 2024; doi: 10.20517/2394-4722.2023.178
|
4 |
Fengxiang Huang, Haiyan Yang, Wenguang Bao, Yehong Bin, Shengsheng Zhou, Man Wang, Xiaoping Lv. Efficacy and safety of trifluridine/tipiracil (TAS-102) in patients with metastatic colorectal cancer: a systematic review and meta-analysis. Clinical and Translational Oncology 2023; 26(2): 468 doi: 10.1007/s12094-023-03268-5
|
5 |
Wen-Tao Zhong, Yuan Lv, Qian-Yu Wang, Ran An, Gang Chen, Jun-Feng Du. Chemoradiotherapy plus tislelizumab for mismatch repair proficient rectal cancer with supraclavicular lymph node metastasis: A case report. World Journal of Gastrointestinal Oncology 2024; 16(5): 2219-2224 doi: 10.4251/wjgo.v16.i5.2219
|
6 |
Marwa Abdel Hamid, Lorenz M. Pammer, Theresa K. Lentner, Bernhard Doleschal, Rebecca Gruber, Florian Kocher, Elisabeth Gasser, Anna Jöbstl, Andreas Seeber, Arno Amann. Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?. Current Oncology Reports 2024; doi: 10.1007/s11912-024-01583-w
|
7 |
Ghizlane Rais, Farah Boutaagount, Rania Mokfi, Meryem Maskrout, Soundous Bennour, Chaymae Senoussi, Fadoua Rais, Laila Lahlou. The Safety and Effectiveness of Bevacizumab in Metastatic Colorectal Cancer With Unresectable Metastases: A Real-Life Study From the South of Morocco. Cureus 2024; doi: 10.7759/cureus.56733
|
8 |
平 盛. Progress in Surgical Treatment of Colorectal Cancer. Advances in Clinical Medicine 2023; 13(11): 17887 doi: 10.12677/ACM.2023.13112510
|
9 |
Qi Liu, Yajuan Zhang, Huimin Li, Hong Gao, Yijie Zhou, Dakui Luo, Zezhi Shan, Yufei Yang, Junyong Weng, Qingguo Li, Weiwei Yang, Xinxiang Li. Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01649-z
|
10 |
Yung-Fu Chang, Hsing-Hsang Wang, Chih-Wen Shu, Wei-Lun Tsai, Cheng-Hsin Lee, Chun-Lin Chen, Pei-Feng Liu. TMEM211 Promotes Tumor Progression and Metastasis in Colon Cancer. Current Issues in Molecular Biology 2023; 45(6): 4529 doi: 10.3390/cimb45060287
|
11 |
Vaagdevi Mukkavilli, Gnanasekaran Ramakrishnan, Koteswara Reddy Gujjula, Balachandran S, Sahiti Chamarthy, Janaki Ramaiah Mekala. Molecular Understanding and Pharmacological Potency of Plant-Derived Compounds in Colorectal Cancer (CRC): A Critical Analysis and Future Perspectives. Cell Biochemistry and Biophysics 2024; doi: 10.1007/s12013-024-01370-1
|
12 |
Qing Cao, Ye Tian, Zhiyi Deng, Fangfang Yang, Erfei Chen. Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications. International Journal of Molecular Sciences 2024; 25(6): 3358 doi: 10.3390/ijms25063358
|
13 |
Edward Zheng, Marcin Włodarczyk, Andrzej Węgiel, Aleksandra Osielczak, Maria Możdżan, Laura Biskup, Agata Grochowska, Maria Wołyniak, Dominik Gajewski, Mateusz Porc, Kasper Maryńczak, Łukasz Dziki. Navigating through novelties concerning mCRC treatment—the role of immunotherapy, chemotherapy, and targeted therapy in mCRC. Frontiers in Surgery 2024; 11 doi: 10.3389/fsurg.2024.1398289
|
14 |
Marco Colella, Andrea Iannucci, Claudia Maresca, Francesco Albano, Carmela Mazzoccoli, Federica Laudisi, Ivan Monteleone, Giovanni Monteleone. SMAD7 Sustains XIAP Expression and Migration of Colorectal Carcinoma Cells. Cancers 2024; 16(13): 2370 doi: 10.3390/cancers16132370
|
15 |
Pengcheng Wang, Wenjin Zhong, Qiaozhen Huang, Yuejia Zhu, Liquan Chen, Kai Ye. Liposome Nanomedicine Based on Tumor Cell Lysate Mitigates the Progression of Lynch Syndrome-Associated Colon Cancer. ACS Biomaterials Science & Engineering 2024; 10(5): 3136 doi: 10.1021/acsbiomaterials.3c01531
|
16 |
Daniel M. DePietro, Xin Li, Susan M. Shamimi-Noori. Chemoembolization Beyond Hepatocellular Carcinoma: What Tumors Can We Treat and When?. Seminars in Interventional Radiology 2024; 41(01): 027 doi: 10.1055/s-0043-1777716
|
17 |
Fei Xing, Ning Liu, Can Wang, Xu-Dong Wang. Caffeic acid phenethyl ester promotes oxaliplatin sensitization in colon cancer by inhibiting autophagy. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-65409-2
|
18 |
Wen-Yu Luan, Hao Lin, Yan-Dong Miao. Recommendations for articles and reviews in colorectal cancer-related research at the year-end of 2023. World Journal of Gastroenterology 2024; 30(30): 3548-3553 doi: 10.3748/wjg.v30.i30.3548
|
19 |
Yanrong Zhan, Xianwen Cheng, Pingping Mei, Shufa Tan, Wenzhe Feng, Hua Jiang. Safety of first-line systemic therapy in patients with metastatic colorectal cancer: a network meta-analysis of randomized controlled trials. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12662-3
|
20 |
Xin Shen, Mengying Xiang, Jiadai Tang, Guangrui Xiong, Ke Zhang, Tingrong Xia, Zhengting Li, Shaoqiong Yang, Xiaoying Chai, Yao Huang, Lin Xie. Evaluation of peripheral blood inflammation indexes as prognostic markers for colorectal cancer metastasis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-68150-y
|